Atea Pharmaceuticals, Inc.
Pharmaceutical company · Boston, Massachusetts, United States · Nasdaq: AVIR
Atea Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2012. Its shares trade on Nasdaq under the ticker AVIR. It has reported private securities offerings to the US SEC, most recently $107 million sold in a notice filed in 2020.
Atea Pharmaceuticals at a glance
What does Atea Pharmaceuticals do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $107.5 million sold (2020).
Frequently asked questions about Atea Pharmaceuticals
Where is Atea Pharmaceuticals headquartered?
Atea Pharmaceuticals, Inc. is headquartered in Boston, Massachusetts, United States.
What does Atea Pharmaceuticals do?
Atea Pharmaceuticals, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Atea Pharmaceuticals a public company?
Yes. Atea Pharmaceuticals, Inc. trades on Nasdaq under the ticker AVIR.
When was Atea Pharmaceuticals founded?
The earliest incorporation on record for Atea Pharmaceuticals, Inc. is in 2012, according to public company registers.
Similar companies
- Transcode Therapeutics, Inc.Boston, Massachusetts, United States
- Akouos, Inc.Boston, Massachusetts, United States
- Astria Therapeutics, Inc.Boston, Massachusetts, United States
- Albireo Pharma, Inc.Boston, Massachusetts, United States
- Rhythm Pharmaceuticals, Inc.Boston, Massachusetts, United States
- Tango Therapeutics, Inc.Boston, Massachusetts, United States
- Paratek Pharmaceuticals, Inc.Boston, Massachusetts, United States
- Praxis Precision Medicines, Inc.Boston, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.